Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
11.66
-0.20 (-1.68%)
Feb 11, 2025, 11:34 AM EST - Market open
DAWN Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for DAWN stock have an average target of 36.17, with a low estimate of 25 and a high estimate of 43. The average target predicts an increase of 210.34% from the current stock price of 11.66.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DAWN stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $48 → $43 | Strong Buy | Maintains | $48 → $43 | +268.94% | Feb 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +183.14% | Jan 13, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +114.50% | Jan 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +243.20% | Oct 31, 2024 |
| Needham | Needham | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +183.14% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
124.27M
Revenue Next Year
168.22M
from 124.27M
Increased by 35.37%
EPS This Year
-0.84
from -2.37
EPS Next Year
-1.19
from -0.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 137.9M | 199.6M | 436.5M | |||
| Avg | 124.3M | 168.2M | 301.9M | |||
| Low | 50.2M | 127.9M | 210.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 60.6% | 159.5% | |||
| Avg | - | 35.4% | 79.5% | |||
| Low | - | 2.9% | 25.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.73 | -0.81 | 0.11 | |||
| Avg | -0.84 | -1.19 | -0.32 | |||
| Low | -1.52 | -1.77 | -0.72 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.